Key result
Novel six-apolipoprotein panel explains ~64% of variance in cardiovascular event risk.
Why the study?
Are baseline plasma concentrations of a broad panel of apolipoproteins associated with the occurrence of cardiovascular events in a general population?
Case-Control (n=130)
Are baseline plasma concentrations of a broad panel of apolipoproteins associated with the occurrence of cardiovascular events in a general population?
Answers are grounded in this paper and cite their sources.
A novel panel of apolipoproteins (A-I, A-IV, C-I, D, H, and J) is independently associated with the occurrence of cardiovascular diseases, suggesting potential as predictive biomarkers.
Background and aims: The role of many apolipoproteins in cardiovascular disease (CVD) pathophysiology and their predictive potential remains unclear. This study examined the association between plasma concentrations of a broad panel of apolipoproteins and the occurrence of cardiovascular events in a general population. Methods: A nested case-control study was conducted within a cohort from Southwestern France. Baseline concentrations of apolipoproteins A-I, A-II, A-IV, B100, C-I, C-II, C-III, D, E, H, J, L1 and M were analyzed in 65 cases who experienced a cardiovascular event during the follow-up period, and in 65 controls matched for age and sex (mean age 60.9 ± 10.7 years; 66.9 % men; median follow up 9.3 years for controls, 6.2 years for cases). Baseline correlations were assessed using Spearman's coefficients.Logistic regression and partial least squares discriminant analysis (PLS-DA) were used to evaluate associations with the occurrence of cardiovascular events. Results: Concentrations of apolipoproteins A-I, A-IV, C-I, D, H, J and M differed significantly between cases and controls. All expect apoM remained independently associated with cardiovascular events after adjustment for known risk factors. Additionally, PLS-DA revealed that the entire apolipoprotein panel explained 64 % of variance in case-control status with 60 % predictive accuracy, with apolipoproteins D, J, A-IV, H, and C-I contributing the most to group discrimination. Conclusions: This study identifies a novel panel of apolipoproteins (A-I, A-IV, C-I, D, H, and J) whose levels are associated with occurrence of cardiovascular diseases, independently of traditional risk factors. Further research is needed to confirm these findings and explore underlying mechanisms.
No takes yet. Share an insight, caveat, or question.
Genoux et al. (2025) conducted a case-control in Cardiovascular events (n=130). Plasma apolipoprotein concentrations vs. Matched controls was evaluated on Occurrence of cardiovascular events. Plasma concentrations of apolipoproteins A-I, A-IV, C-I, D, H, and J were independently associated with cardiovascular events, with the panel explaining 64% of variance in case-control status.
Synapse has enriched 10 related papers. Consider them for comparative context: